{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-quality-management-system-qms-in-clinical-research”
},
“headline”: “SOP for Quality Management System (QMS) in Clinical Research”,
“description”: “This SOP establishes procedures for implementing and maintaining a Quality Management System (QMS) in clinical research, ensuring compliance with FDA, EMA, CDSCO, WHO, and ICH GCP guidelines. It covers SOP management, CAPA, audits, training, and continuous quality improvement.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}
Published on 21/12/2025
Standard Operating Procedure for Quality Management System (QMS) in Clinical Research
| SOP No. | CR/OPS/095/2025 |
| Supersedes | NA |
| Page No. | 1 of 45 |
| Issue Date | 26/08/2025 |
| Effective Date | 01/09/2025 |
| Review Date | 01/09/2026 |
Purpose
The purpose of this SOP is to define the framework for establishing and maintaining a Quality Management
Scope
This SOP applies to sponsors, CROs, investigators, QA, and vendors involved in the planning, execution, monitoring, and reporting of clinical trials. It covers quality risk management, deviation handling, CAPA, SOP management, training, audits, inspections, and continuous quality improvement processes.
Responsibilities
- Sponsor: Establishes and oversees the QMS across clinical programs.
- QA: Monitors compliance, performs audits, and manages CAPA.
- Investigators: Implement QMS practices at site level.
- CROs: Align QMS processes with sponsor requirements.
- Vendors: Maintain QMS compliance in outsourced activities.
Accountability
The Sponsor’s Quality Head is accountable for implementing and maintaining QMS practices. QA is accountable for oversight, ensuring compliance, and preparing for audits and inspections.
Procedure
1. QMS Framework
1.1 Establish QMS aligned with ICH E6(R2/R3) principles.
1.2 Define QMS processes for planning, execution, oversight, and reporting.
1.3 Document policies, SOPs, and work instructions in a controlled system.
2. SOP Management
2.1 Create, approve, and maintain SOPs in line with QMS.
2.2 Maintain SOP Master Log (Annexure-1).
2.3 Review and update SOPs periodically (at least every 2 years).
3. Quality Risk Management
3.1 Identify risks in trial activities using a risk assessment matrix.
3.2 Document risk mitigation in Risk Management Log (Annexure-2).
3.3 Monitor risks throughout the trial lifecycle.
4. Deviation and CAPA Management
4.1 Record deviations in Deviation Log (Annexure-3).
4.2 Investigate root causes and implement CAPA.
4.3 Track CAPA status in CAPA Log (Annexure-4).
5. Training
5.1 All staff must receive QMS and GCP training.
5.2 Document training in Training Log (Annexure-5).
6. Audits and Inspections
6.1 QA conducts internal audits to verify QMS compliance.
6.2 Maintain Audit Log (Annexure-6).
6.3 Ensure readiness for regulatory inspections.
7. Continuous Quality Improvement
7.1 Review quality metrics quarterly.
7.2 Conduct Management Review Meetings to evaluate QMS performance.
7.3 Implement process improvements based on findings.
Abbreviations
- SOP: Standard Operating Procedure
- QMS: Quality Management System
- QA: Quality Assurance
- CRO: Contract Research Organization
- CAPA: Corrective and Preventive Action
- TMF: Trial Master File
- ISF: Investigator Site File
Documents
- SOP Master Log (Annexure-1)
- Risk Management Log (Annexure-2)
- Deviation Log (Annexure-3)
- CAPA Log (Annexure-4)
- Training Log (Annexure-5)
- Audit Log (Annexure-6)
References
- ICH E6(R2/R3) – Quality Management Principles
- FDA – QMS in Clinical Trials Guidance
- EMA – Oversight of Clinical Quality Systems
- CDSCO – Quality System Requirements
- WHO – Quality Management in Clinical Research
Version: 1.0
Approval Section
| Prepared By | Ravi Kumar, QA Specialist |
| Checked By | Sunita Reddy, QA Officer |
| Approved By | Dr. Anil Sharma, Head Clinical Quality |
Annexures
Annexure-1: SOP Master Log
| SOP No. | Title | Version | Effective Date | Reviewed By |
|---|---|---|---|---|
| CR/OPS/095/2025 | QMS in Clinical Research | 1.0 | 01/09/2025 | QA Officer |
Annexure-2: Risk Management Log
| Date | Risk Identified | Impact | Mitigation | Responsible |
|---|---|---|---|---|
| 10/09/2025 | Delayed Monitoring Visit | High | Reschedule within 2 weeks | CRA |
Annexure-3: Deviation Log
| Date | Deviation | Root Cause | Action Taken | Status |
|---|---|---|---|---|
| 12/09/2025 | Missing signature on ICF | Human error | Re-training provided | Closed |
Annexure-4: CAPA Log
| Date | CAPA ID | Issue | Corrective Action | Preventive Action | Status |
|---|---|---|---|---|---|
| 15/09/2025 | CAPA-2025-01 | Deviation recurrence | Revise SOP | Increase training frequency | Open |
Annexure-5: Training Log
| Date | Name | Role | Training Topic | Trainer |
|---|---|---|---|---|
| 01/09/2025 | Meena Sharma | CRA | QMS and GCP | QA Officer |
Annexure-6: Audit Log
| Date | Audit Type | Findings | CAPA Required | Auditor |
|---|---|---|---|---|
| 20/09/2025 | Internal Audit | Minor documentation gaps | Yes | QA Manager |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 26/08/2025 | 00 | Initial version | New SOP creation | Head Clinical Quality |
For more SOPs visit: Pharma SOP